The research time span covered by the report is from 2019 to 2030; it provides an overview of the Global Biodefense Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Biodefense market size in 2023 is 15700.0 million US dollars, and it is expected to be 28516.4 million US dollars by 2030, with a compound annual growth rate of 8.9% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Biodefense market include XOMA corporation, Altimmune Inc., Emergent Biosolutions Inc., Dynavax Technologies Corporation., and SIGA Technologies.. The share of the top 3 players in the Biodefense market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Biodefense market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Anthrax accounted for XX% of Biodefense market in 2023. Botulism share of XX%.
Civilian accounted for XX% of the Biodefense market in 2023. Military accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it”s going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapters 2-4: Segmented the global Biodefense market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Biodefense market country revenue data, and includes PEST Analysis.
Chapter 10: Analysis of the competitive environment of Biodefense market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Biodefense industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 12-14: Provide detailed Biodefense market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
XOMA corporation
Altimmune Inc.
Emergent Biosolutions Inc.
Dynavax Technologies Corporation.
SIGA Technologies.
Elusys Therapeutics Inc.
Ichor Medical Systems.
Dynport Vaccine Company.
Cleveland Biolabs.
Bavarian Nordic.
Ology Bioservices.
Types list
Anthrax
Botulism
Application list
Civilian
Military
List of Tables and Figures
Figure Biodefense Picture
Table Product Definition of Biodefense
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Biodefense Market Size by Type (2019 VS 2024 VS 2030)
Table Global Biodefense Revenue by Type (2019-2024)
Table Global Biodefense Revenue and Share by Type (2019-2024)
Table Global Biodefense Market Size by Application (2019 VS 2024 VS 2030)
Table Global Biodefense Revenue by Application (2019-2024)
Table Global Biodefense Revenue Share by Application (2019-2024)
Figure Global Biodefense Revenue Market Size Growth (2019-2024)
Table Biodefense Market Size by Regions: 2019 VS 2024 VS 2030
Table Biodefense Revenue Market Size by Regions (2019-2024)
Table Biodefense Revenue and Share by Regions (2019-2024)
Figure North America Biodefense Market Size (2019-2024)
Figure Europe Biodefense Market Size (2019-2024)
Figure Asia-Pacific Biodefense Market Size (2019-2024)
Figure Latin America Biodefense Market Size (2019-2024)
Figure Middle East & Africa Biodefense Market Size (2019-2024)
Table North America Biodefense Revenue by Countries (2019-2024)
Table North America Biodefense Revenue and Share by Countries (2019-2024)
Table North America PEST Analysis
Figure United States Biodefense Revenue and Growth (2019-2024)
Figure Canada Biodefense Revenue and Growth (2019-2024)
Figure Canada Biodefense Sales and Growth (2019-2024)
Table Asia-Pacific Biodefense Revenue by Countries (2019-2024)
Table Asia-Pacific Biodefense Revenue and Share by Countries (2019-2024)
Table Asia-Pacific PEST Analysis
Figure China Biodefense Revenue and Growth (2019-2024)
Figure Japan Biodefense Revenue and Growth (2019-2024)
Figure Korea Biodefense Revenue and Growth (2019-2024)
Figure Southeast Asia Biodefense Revenue and Growth (2019-2024)
Figure India Biodefense Revenue and Growth (2019-2024)
Figure Australia Biodefense Revenue and Growth (2019-2024)
Table Europe Biodefense Revenue by Countries (2019-2024)
Table Europe Biodefense Revenue and Share by Countries (2019-2024)
Table Europe PEST Analysis
Figure Germany Biodefense Revenue and Growth (2019-2024)
Figure France Biodefense Revenue and Growth (2019-2024)
Figure UK Biodefense Revenue and Growth (2019-2024)
Figure Italy Biodefense Revenue and Growth (2019-2024)
Figure Russia Biodefense Revenue and Growth (2019-2024)
Figure Spain Biodefense Revenue and Growth (2019-2024)
Figure Nordic Biodefense Revenue and Growth (2019-2024)
Table Latin America Biodefense Revenue by Countries (2019-2024)
Table Latin America Biodefense Revenue and Share by Countries (2019-2024)
Table Latin America PEST Analysis
Figure Brazil Biodefense Revenue and Growth (2019-2024)
Figure Argentina Biodefense Revenue and Growth (2019-2024)
Figure Mexico Biodefense Revenue and Growth (2019-2024)
Table Middle East & Africa Biodefense Revenue by Countries (2019-2024)
Table Middle East & Africa Biodefense Revenue and Share by Countries (2019-2024)
Table Middle East & Africa PEST Analysis
Figure Egypt Biodefense Revenue and Growth (2019-2024)
Figure South Africa Biodefense Revenue and Growth (2019-2024)
Figure UAE Biodefense Revenue and Growth (2019-2024)
Figure Turkey Biodefense Revenue and Growth (2019-2024)
Figure Saudi Arabia Biodefense Revenue and Growth (2019-2024)
Table Global Biodefense Revenue by Players (2019-2024)
Table Global Biodefense Revenue Market Share by Players (2019-2024)
Figure Global Top 3 Companies Revenue Share in 2023
Figure Global Top 6 Companies Revenue Share in 2023
Table Global Biodefense Players Market Concentration Ratio (CR5) (2019-2024)
Table Biodefense Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table XOMA corporation Profile
Table Product Overview
Table XOMA corporation Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure XOMA corporation Revenue and Growth Rate
Figure XOMA corporation Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Altimmune Inc. Profile
Table Product Overview
Table Altimmune Inc. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Altimmune Inc. Revenue and Growth Rate
Figure Altimmune Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Emergent Biosolutions Inc. Profile
Table Product Overview
Table Emergent Biosolutions Inc. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Emergent Biosolutions Inc. Revenue and Growth Rate
Figure Emergent Biosolutions Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Dynavax Technologies Corporation. Profile
Table Product Overview
Table Dynavax Technologies Corporation. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Dynavax Technologies Corporation. Revenue and Growth Rate
Figure Dynavax Technologies Corporation. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table SIGA Technologies. Profile
Table Product Overview
Table SIGA Technologies. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure SIGA Technologies. Revenue and Growth Rate
Figure SIGA Technologies. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Elusys Therapeutics Inc. Profile
Table Product Overview
Table Elusys Therapeutics Inc. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Elusys Therapeutics Inc. Revenue and Growth Rate
Figure Elusys Therapeutics Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Ichor Medical Systems. Profile
Table Product Overview
Table Ichor Medical Systems. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Ichor Medical Systems. Revenue and Growth Rate
Figure Ichor Medical Systems. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Dynport Vaccine Company. Profile
Table Product Overview
Table Dynport Vaccine Company. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Dynport Vaccine Company. Revenue and Growth Rate
Figure Dynport Vaccine Company. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Cleveland Biolabs. Profile
Table Product Overview
Table Cleveland Biolabs. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Cleveland Biolabs. Revenue and Growth Rate
Figure Cleveland Biolabs. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Bavarian Nordic. Profile
Table Product Overview
Table Bavarian Nordic. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Bavarian Nordic. Revenue and Growth Rate
Figure Bavarian Nordic. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Ology Bioservices. Profile
Table Product Overview
Table Ology Bioservices. Biodefense Revenue, Gross and Gross Margin (2019-2024)
Figure Ology Bioservices. Revenue and Growth Rate
Figure Ology Bioservices. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Global Biodefense Revenue Forecast by Type (2024-2030)
Table Global Biodefense Revenue and Share Forecast by Type (2024-2030)
Table Global Biodefense Revenue by Application (2024-2030)
Table Global Biodefense Revenue and Share by Application (2024-2030)
Figure Global Biodefense Revenue Forecast Market Size (2024-2030)
Table Biodefense Revenue Forecast by Regions (2024-2030)
Table Biodefense Revenue and Share Forecast by Regions (2024-2030)
Figure North America Biodefense Revenue Forecast Market Size (2024-2030)
Figure Europe Biodefense Revenue Forecast Market Size (2024-2030)
Figure Asia-Pacific Biodefense Revenue Forecast Market Size (2024-2030)
Figure Latin America Biodefense Revenue Forecast Market Size (2024-2030)
Figure Middle East & Africa Biodefense Revenue Forecast Market Size (2024-2030)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
